Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07069478 · ClinicalTrials.gov registry record · NA

Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms

A NA study of Stress and CBD, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
125
Enrollment target
1
Study location

NCT07069478 is a NA study of Stress and CBD that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 125 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07069478, a NA study of Stress and CBD, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the effects of regular cannabidiol (CBD) use on the psychobiological mechanisms of the stress response. This will be achieved by comparing acute stress responses of adults who either use or do not use CBD regularly. Correlates of CBD use, including tobacco use, will be collected.

Interventions

  • OTHER Stress Intervention

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2025-06-01
Est. Completion 2026-11-30
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07069478

The ClinicalTrials.gov registry entry for NCT07069478 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 152 other Stress trials with a reported enrollment target (84% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Stress Intervention is the first listed.

NCT07069478 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07069478 about?

NCT07069478 is a clinical study titled "Cannabidiol (CBD) and Stress Response: Psychobiological Mechanisms". The aim of this study is to determine the effects of regular cannabidiol (CBD) use on the psychobiological mechanisms of the stress response. This will be achieved by comparing acute stress responses of adults who either use or do not use CBD regularly. Correlates of CBD use, including tobacco use, ...

What is the current status of trial NCT07069478?

This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2025-06-01. Estimated completion is 2026-11-30.

What conditions does trial NCT07069478 study?

This clinical trial studies the following conditions: Stress, CBD, Acute Stress Reaction, Cannabidiol.

What interventions are being tested in trial NCT07069478?

The interventions under investigation include: Stress Intervention (OTHER).

Who is sponsoring clinical trial NCT07069478?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07069478 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.